Welcome to LookChem.com Sign In|Join Free
  • or
2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione is a complex organic compound with the molecular formula C12H14N2O2. It is a derivative of imidazole, a heterocyclic aromatic organic compound containing two nitrogen atoms. The structure of 2-phenyltetrahydro-1H-pyrrolo[1,2-c]imidazole-1,3(2H)-dione features a pyrrolo[1,2-c]imidazole core, which is a fused ring system consisting of a pyrrole and an imidazole. The 2-phenyl group attached to the tetrahydro ring provides additional stability and contributes to the compound's unique properties. This chemical is primarily of interest in the field of medicinal chemistry, as it may possess potential biological activities and could be a starting point for the development of new drugs. However, further research and characterization are needed to fully understand its properties and potential applications.

2221-09-2

Post Buying Request

2221-09-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2221-09-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2221-09-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,2 and 1 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2221-09:
(6*2)+(5*2)+(4*2)+(3*1)+(2*0)+(1*9)=42
42 % 10 = 2
So 2221-09-2 is a valid CAS Registry Number.

2221-09-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-phenyl-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazole-1,3-dione

1.2 Other means of identification

Product number -
Other names 2-Phenyl-2,5,6,7,7a-pentahydro-2-azapyrrolizine-1,3-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2221-09-2 SDS

2221-09-2Downstream Products

2221-09-2Relevant academic research and scientific papers

Microwave-assisted solid-phase synthesis of hydantoin derivatives

Colacino, Evelina,Lamaty, Frédéric,Martinez, Jean,Parrot, Isabelle

, p. 5317 - 5320 (2008/02/09)

A microwave-assisted synthesis of 3,5- and 1,3,5-substituted hydantoins starting from various resins for solid-phase combinatorial chemistry has been developed. The hydantoins were synthesized from pre-loaded resins with amino acids via treatment with isocyanate or phenylisocyanate and subsequent intramolecular cyclization. Both reactions were performed under microwave irradiation. We studied the cyclative cleavage leading to hydantoin compounds dependent on the nature of the amino acid and the nucleofuge properties of the resin.

Method for treating nerve injury caused as a result of surgery

-

, (2008/06/13)

The present invention relates generally to methods for treating or preventing nerve injury in a warm-blooded animal caused as a consequence of surgery by administering neurotrophic compounds described below. The invention relates more specifically to methods for treating or preventing nerve injury caused as a consequence of prostate surgery as well as erectile dysfunction.

Hydantoin derivative compounds, pharmace utical compositions, and methods of using same

-

, (2008/06/13)

The present invention relates generally to novel hydantoin derivative compounds, pharmaceutical compositions containing such compounds, and methods for their use in preventing and/or treating neurological disorders, including physically damaged nerves and neurodegenerative diseases; for treating alopecia and promoting hair growth; for treating vision disorders and/or improving vision; for treating memory impairment and/or enhancing memory performance; and for treating sensorineural hearing loss by administering such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2221-09-2